12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Company News  |  Deals

OxiGene, Boston Medical Center deal

The center, affiliated with Boston University Medical Center, will collaborate with the company under a sponsored research agreement to study OXGN's Neu-Sensamide and Oxi-104 as chemosensitizers of cordycepin...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >